Long term follow-up of women treated for screen detected atypical ductal hyperplasia or lobular neoplasia in a large UK screening centre
2024

Long-term follow-up of women with atypical ductal hyperplasia or lobular neoplasia

Sample size: 107 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nicole L. Brown, Susan Pritchard, Elaine F. Harkness, Yit Lim, Ashu Gandhi, Dafydd Gareth Evans, Anthony Howell, Sacha J. Howell

Primary Institution: Manchester University NHS Foundation Trust

Hypothesis

What are the management and outcomes of women with atypical ductal hyperplasia and lobular neoplasia?

Conclusion

Most breast cancers in women with atypical ductal hyperplasia or lobular neoplasia occur beyond five years, suggesting that enhanced screening regimens should extend to at least 10 years.

Supporting Evidence

  • 14.3% of women developed breast cancer after a median follow-up of 117 months.
  • 15 out of 107 women were diagnosed with breast cancer.
  • The incidence rate of breast cancer was 1499.6 per 100,000 women per year.

Takeaway

Women with certain breast conditions are at a higher risk of developing breast cancer, especially after five years, so they need more frequent check-ups.

Methodology

Women diagnosed with atypical ductal hyperplasia and/or lobular neoplasia between 2010-2018 were identified, and data were extracted from electronic patient records.

Potential Biases

Potential for incomplete ascertainment as some women may have moved away without follow-up.

Limitations

The sample size is relatively small, and there may be incomplete follow-up data for some patients.

Participant Demographics

Median age at diagnosis was 53 years, with a majority being White (71%).

Statistical Information

P-Value

0.037

Confidence Interval

95% CI 7.5–8.8%

Statistical Significance

p=0.037

Digital Object Identifier (DOI)

10.1038/s44276-024-00113-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication